Babies surviving Group B strep more likely to require special educational support
(London School of Hygiene& Tropical Medicine) Invasive Group B Streptococcus (GBS) disease, notably meningitis, during the first days and months of a baby's life can have persistent effects for children and hence their families, according to new research. Published in the Lancet Child& Adolescent Health, the study is the first evidence of long-term effects including after GBS sepsis (infection in the bloodstream). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 21, 2021 Category: Infectious Diseases Source Type: news
Will Trust in the Johnson & Johnson Vaccine Recover? Europe ’s AstraZeneca Experience Suggests Not
When the U.S. Food and Drug Administration and Centers for Disease Control and Prevention recommended stopping use of the Johnson & Johnson/Janssen COVID-19 vaccine on April 13, they declared the action a “pause”—a brief intermission as the government investigates a possible link between the vaccine and blood clots in a small number of recipients. The agencies may lift that recommendation as soon as this week, and vaccination with the Pfizer-BioNTech and Moderna shots has continued.
However temporary it might be, a recent YouGov/Economist survey suggests that the J&J pause has already hurt U.S. pu...
Source: TIME: Health - April 20, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Source Type: news
Job vacancies in evidence synthesis with Cochrane Infectious Diseases group - Liverpool, UK
Liverpool School of Tropical Medicine ’s Centre for Evidence Synthesis in Global Health has led developments in systematic reviews in tropical medicine and international health. In the 1990s, staff contributed to setting up Cochrane, and established theCochrane Infectious Diseases Group (CIDG). This is now recognised as one of Cochrane ’s premier groups, with over 150 Cochrane reviews and 600 authors, and is well-linked with the World Health Organization.Two job positions are currently being advertised with the Centre (Research Assistant and Clinical Research Associate in evidence synthesis). A further position ...
Source: Cochrane News and Events - April 8, 2021 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Job vacancy: Research Associate (Evidence Synthesis)- Liverpool, UK
Liverpool School of Tropical Medicine ’s Centre for Evidence Synthesis in Global Health has led developments in systematic reviews in tropical medicine and international health. In the 1990s, staff contributed to setting up Cochrane, and established theCochrane Infectious Diseases Group (CIDG). This is now recognised as one of Cochrane ’s premier groups, with over 150 Cochrane reviews and 600 authors, and is well-linked with the World Health Organization.Based in Liverpool, an exciting opportunity has arisen for a Research Associate to join the team of 11 staff to contribute to the broad programme of research and dev...
Source: Cochrane News and Events - April 8, 2021 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Brazil at high risk of dengue outbreaks after droughts because of temporary water storage
(London School of Hygiene& Tropical Medicine) Dengue risk is exacerbated in highly populated areas of Brazil after extreme drought because of improvised water containers housing mosquitoes, suggests a new study in Lancet Planetary Health.The research was led by the London School of Hygiene& Tropical Medicine's (LSHTM) Centre on Climate Change& Planetary Health and Centre for the Mathematical Modelling of Infectious Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 8, 2021 Category: Infectious Diseases Source Type: news
Three Ways the US Can Promote Equity in Ending the COVID-19 Pandemic Globally
Continued inequity in COVID-19 vaccination means virus mutations occur and newer variants emerge that may be resistant to currently available vaccines. Credit: United Nations.By Ifeanyi NsoforABUJA, Apr 2 2021 (IPS) As richer western nations continue hoarding COVID-19 vaccines to the detriment of poorer nations, there is some light on the horizon. On April 15, 2021, the U.S. will join the Global Vaccine Alliance (GAVI) and co-host the launch of the Investment Opportunity for COVAX Advance Market Commitment.
The aim of the event is to raise more funds to ensure at least 1.8 million doses of COVID-19 vaccines are available ...
Source: IPS Inter Press Service - Health - April 2, 2021 Category: International Medicine & Public Health Authors: Ifeanyi Nsofor Tags: Global Headlines Health Source Type: news
Vulnerable newborns being separated from their mothers in COVID-19 pandemic
(London School of Hygiene& Tropical Medicine) The COVID-19 pandemic is affecting the quality of care given to small and sick newborn babies in all regions of the world and threatening implementation of life-saving interventions, suggests new research published in BMJ Global Health. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 15, 2021 Category: Infectious Diseases Source Type: news
New AJTMH supplement offers guidance on severe COVID-19 management in resource-limited settings
(Burness) A new supplement offering guidance on severe COVID-19 management in resource-limited settings is now available on the American Journal of Tropical Medicine (AJTMH) website. Pragmatic Recommendations for the Management of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries was coordinated by a COVID-LMIC Task Force headed by Alfred Papali, MD, of Atrium Health, Charlotte, NC, and Marcus Schultz, MD, PhD, of Mahidol University, Bangkok, Thailand; University of Oxford, United Kingdom; and Amsterdam University Medical Centers, The Netherlands. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 12, 2021 Category: International Medicine & Public Health Source Type: news
COVID-19 Cases Are Rising in Europe, and the Vaccine Rollout Is Lagging. How Did It All Go So Badly Wrong?
Europe was one of the first regions to be hit hard by COVID-19 last spring. In mid-May 2020, the World Health Organization declared it the “epicenter” of the pandemic, with more reported cases and deaths than the rest of the world combined. From there, in many ways, the European experience of COVID-19 mirrored the U.S. and its neighbor the U.K., two of the other worst-hit parts of the globe: In the summer, many bars, restaurants and clubs reopened their doors, and international visitors were welcomed back. Then cases began to surge again in the autumn and winter, in large part thanks to the holidays, and lockdo...
Source: TIME: Health - March 11, 2021 Category: Consumer Health News Authors: Madeline Roache Tags: Uncategorized COVID-19 Londontime Source Type: news
Frontiers Removes Controversial Ivermectin Paper Pre-Publication
A review article containing contested claims about the tropical medicine drug as a COVID-19 treatment was listed as "provisionally accepted" on the journal's website before being removed this week. (Source: The Scientist)
Source: The Scientist - March 2, 2021 Category: Science Tags: News & Opinion Source Type: news
‘I’ve had my vaccine - how well will it protect me and for how long?’
The latest answers to the important medical questions about the vaccines and the pandemicCoronavirus – latest updatesSee all our coronavirus coverageThe prospects of vaccines failing to trigger immune responses are dismissed as remote by scientists. “If a vaccine has not been properly refrigerated that might pose problems but doctors take great care to ensure that doesn’t happen,” said Professor Helen Fletcher at the London School of Hygiene& Tropical Medicine. “Frankly the only other way to get a failed reaction is for the doctor to miss your arm – which isn’t likely.”Continue reading... (Source: Guard...
Source: Guardian Unlimited Science - February 27, 2021 Category: Science Authors: Robin McKie Tags: Coronavirus Infectious diseases Medical research Science Vaccines and immunisation UK news Source Type: news
TB vaccine may protect newborns against other infectious diseases
(London School of Hygiene& Tropical Medicine) The tuberculosis (TB) vaccine Bacillus Calmette-Guerin (BCG) could protect newborns against a variety of common infections, such as upper respiratory tract infections, chest infections and diarrhoea, according to a new study in Lancet Infectious Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 17, 2021 Category: Infectious Diseases Source Type: news
High public support for strict COVID measures but lower level of trust in gov
(London School of Hygiene& Tropical Medicine) High levels of public support for strict measures to control COVID-19 during the first wave of the pandemic did not reflect high levels of public trust in the UK government's honesty, transparency or motives, suggests a new study published in PLOS One. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 16, 2021 Category: Infectious Diseases Source Type: news
Self-testing trebles HIV testing rate amongst trans people in randomised trial
(London School of Hygiene& Tropical Medicine) HIV self-testing could reduce the time between HIV infection and HIV diagnosis amongst trans people when compared to standard testing services, suggests new research inEClinicalMedicine.The project was a collaboration between the London School of Hygiene& Tropical Medicine (LSHTM), University College London (UCL), and the Medical Research Council Clinical Trials Unit. It involved more than 100 trans men and trans women in England and Wales, and is the largest HIV self-testing trial in this community to be reported. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 11, 2021 Category: Infectious Diseases Source Type: news
Job vacancies with Cochrane Infectious Diseases - Liverpool, UK
The Centre for Evidence Synthesis in Global Health has led developments in systematic reviews in tropical medicine and international health. In the 1990s, staff contributed to setting up Cochrane, and established theCochrane Infectious Diseases Group (CIDG). This is now recognised as one of Cochrane ’s premier groups, with over 150 Cochrane reviews and 600 authors, and is well-linked with the World Health Organization. Two job positions are currently being advertised with the Centre.Take a look at www.evidence4health.org/ and https://cidg.cochrane.org/ where you will find annual reports of our work and learn ...
Source: Cochrane News and Events - February 10, 2021 Category: Information Technology Authors: Muriah Umoquit Source Type: news
